Ideal for bodybuilders and gym goers, CJC DAC-1295 can also break down fat tissue. Its ability to distribute fat deposits and adipose tissue can even improve the look and feel of skin, blurring wrinkles in the process. And with the benefit of enhancing bone density and supercharging injury recovery, it ultimately aids in keeping the body fit and strong.
- Increases production of growth hormones
- Supports muscle, bone and tissue growth
- Promotes injury recovery
- Breaks down excess fat
- Improves bone density
- Enhances skin appearance and texture
Product Name: CJC-1295 with DAC
Molecular Formula: C152H252N44O42
CJC-1295 with DAC is a synthetic variant of growth hormone releasing hormone and is a performance peptide hormone that increases both the production of growth hormone and IGF-1 in healthy adult subjects.
A single injection in human subjects increases plasma growth hormone levels by up to tenfold for six days and plasma IGF-1 levels by up to threefold for eleven days.
Because of its long half-life in humans it remains active for longer periods of time and increases the bioavailability of growth hormone releasing hormone.
In addition to this, CJC-1295 with DAC breaks down fat tissue, boosts injury recovery and enhances bone density.
It has also been purported to reduce ageing factors such as skin wrinkles and improve skin quality. This makes sense because peptide was initially being developed for the treatment of lipodystrophy and growth hormone deficiency and reached phase II clinical trials. It acts to help distribute fat deposits and adipose tissue which has a drastic impact on skin look and texture.
CJC-1295 is sold in vials containing 2MG of lyophilised powder which can be reconstituted by adding a convenient amount of sterile or bacteriostatic water.
Vial size: 5mg
Recommended dose: 0.2mg – 0.4mg per day for 4 weeks on, 2 weeks off for wound repair and injury recovery.
Amount of water to add: 2.5ml of bacteriostatic water.
Resulting concentration: 2mg/ml.
Recommended frequency of dose: Once per day.
CJC DAC-1295 is a growth hormone-releasing peptide (GHRP) analog developed for research purposes. This peptide has been made to elevate muscle mass, decrease fat stores, and enhance physical performance, stimulating the secretion of growth hormone and insulin-like growth factor 1 (IGF-1). Its primary use can be found for subjects looking to improve their fitness, weight loss, and muscle growth.
Taking longer to kick in than other drugs, CJC DAC-1295 draws out its full potential over time. It keeps a continual rise of HGH and IGF-1 circulating in the body with zero prolactin. This leads to more targeted fat loss while increasing protein synthesis for lean muscle growth.
CJC DAC-1295 should be taken at a maximum dosage of 2mg per week, consumed daily or all at once. It targets the subject’s pituitary gland and causes an increase in IGF-1 levels and secretion of other hormones such as Cortisol, Insulin, and Glucose.
Clinical studies on CJC DAC-1295 demonstrate potential as a therapeutic agent. The subcutaneous administration was safe and well tolerated, particularly at 30 or 60 microg/kg doses. Furthermore, the product revealed an impressive half-life of up to 8 days, with evidence exhibiting cumulative effects after repetitive dosing cycles, potentially providing subjects with long-lasting GH and IGF-I levels.
CJC DAC-1295 is often paired with other peptide and hormone therapies, such as GHRP-6 or GHRP-2, to enhance fat loss, muscle growth, and performance. When using such products, dosing and administering guidelines should be strictly followed.